Altered miRNA expression in pulmonary sarcoidosis
Authors:
- Justyna KiszałkiewiczJKJustyna Kiszałkiewicz
- Wojciech J. PiotrowskiWojciech J. Piotrowski
- Dorota Pastuszak-LewandoskaDorota Pastuszak-Lewandoska
- Paweł GórskiPGPaweł Górski
- Adam AntczakAAAdam Antczak
- Witold GórskiWGWitold Górski
- Daria Domańska-SenderowskaDDDaria Domańska-Senderowska
- Monika Migdalska-SękMMMonika Migdalska-Sęk
- Karolina H. CzarneckaKCKarolina H. Czarnecka
- Ewa NawrotENEwa Nawrot
- Ewa Brzeziańska-LasotaEBEwa Brzeziańska-Lasota
Open Access
- 14 January 2016
- journal article
- research article
- Published by Springer Nature in BMC Medical Genetics
- Vol. 17 (1) , 1-12
Abstract
MiRNAs control important cellular functions including angiogenesis/angiostasis or fibrosis and reveal altered expression during pathological processes in the lung. The aim of the study was to investigate the expression of selected miRNAs (miR-let7f, miR-15b, miR-16, miR-20a, miR-27b, miR-128a, miR-130a, miR-192 miR-221, miR-222) in patients with pulmonary sarcoidosis (n = 94) and controls (n = 50). The expression was assessed by q-PCR in BALF cells and peripheral blood lymphocytes (PB lymphocytes). For statistical analysis, the Kruskal–Wallis test, Mann–Whitney U- test, Neuman–Keuls’ multiple comparison test, and Spearman’s rank correlation were used. In BALF cells, significantly higher expression of miR-192 and miR-221 and lower expression of miR-15b were found in patients than controls. MiR-27b, miR-192 and miR-221 expression was significantly higher in patients without parenchymal involvement (stages I) than those at stages II-IV. Patients with acute disease demonstrated significantly higher miR-27b, miR-192 and miR-221 expression than those with insidious onset. For PB lymphocytes, patients demonstrated significantly greater miR-15b, miR-27b, miR-192, miR-221 and miR-222 expression, but lower miR-let7f and miR-130a expression, than controls. Stage I patients demonstrated significantly higher miR-16 and miR-15b expression than those in stages II-IV, and patients with the acute form demonstrated higher miR-130a and miR-15b expression. In BALF cells, miR-16 and miR-20a expression was significantly higher in patients with lung volume restriction, and miR-let7f was higher in the PB lymphocytes in patients with obturation. Several correlations were observed between the pattern of miRNA expression, lung function parameters and selected laboratory markers. The obtained results suggest that the studied miRNAs play a role in the pathogenesis of sarcoidosis, and that some of them might have negative prognostic value.Keywords
This publication has 49 references indexed in Scilit:
- Common patterns and disease-related signatures in tuberculosis and sarcoidosisProceedings of the National Academy of Sciences, 2012
- MicroRNA-16 and MicroRNA-424 Regulate Cell-Autonomous Angiogenic Functions in Endothelial Cells via Targeting Vascular Endothelial Growth Factor Receptor-2 and Fibroblast Growth Factor Receptor-1Arteriosclerosis, Thrombosis, and Vascular Biology, 2011
- Comprehensive microRNA analysis in bleomycin-induced pulmonary fibrosis identifies multiple sites of molecular regulationPhysiological Genomics, 2011
- miR-21 mediates fibrogenic activation of pulmonary fibroblasts and lung fibrosisJournal of Experimental Medicine, 2010
- Inhibition and Role of let-7d in Idiopathic Pulmonary FibrosisAmerican Journal of Respiratory and Critical Care Medicine, 2010
- Role of specific microRNAs for endothelial function and angiogenesisBiochemical and Biophysical Research Communications, 2009
- miR-126 Regulates Angiogenic Signaling and Vascular IntegrityDevelopmental Cell, 2008
- MicroRNA targets in immune genes and the Dicer/Argonaute and ARE machinery componentsMolecular Immunology, 2008
- Maternally imprinted microRNAs are differentially expressed during mouse and human lung developmentDevelopmental Dynamics, 2006
- MicroRNAs: small RNAs with a big role in gene regulationNature Reviews Genetics, 2004